Zymeworks (ZYME) Payables (2021 - 2026)

Zymeworks has disclosed Payables across 6 years of filings, most recently posting $30.2 million for Q1 2026.

• Payables for Q1 2026 came in at $30.2 million, down 20.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.2 million (down 20.92% YoY), and the FY2025 annual result was $36.3 million, down 39.26% from the prior year.
• Payables came in at $30.2 million for Q1 2026 at Zymeworks, down from $36.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $87.5 million in Q4 2022 to a low of $30.2 million in Q1 2026.
• The 5-year median for Payables is $47.4 million (2024), against an average of $50.4 million.
• Across the five-year window, Payables soared 39.3% in 2022 and slumped 47.42% in 2023, its largest moves.
• Zymeworks' Payables stood at $87.5 million in 2022, then slumped by 47.42% to $46.0 million in 2023, then surged by 30.11% to $59.8 million in 2024, then sank by 39.26% to $36.3 million in 2025, then declined by 16.84% to $30.2 million in 2026.
• The last three Payables figures came in at $30.2 million (Q1 2026), $36.3 million (Q4 2025), and $34.4 million (Q3 2025), per Business Quant data.